New York State Common Retirement Fund Terns Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $75.2 Billion
- Q2 2025
A detailed history of New York State Common Retirement Fund transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 17,571 shares of TERN stock, worth $142,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,571
Previous 17,571
-0.0%
Holding current value
$142,500
Previous $48,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TERN
# of Institutions
133Shares Held
84.2MCall Options Held
173KPut Options Held
89.5K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$66.2 Million2.36% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$61.3 Million1.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.5MShares$60.8 Million0.99% of portfolio
-
Morgan Stanley New York, NY7.25MShares$58.8 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$55.9 Million5.45% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $305M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...